reports
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders It Has F...
NEW YORK--(BUSINESS WIRE)-- The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired shares of Egalet Corporation (“Egalet”) (NASDAQ: EGLT) between December 15, 2015 and January 9, 2017. You are hereby notified that Levi & Korsinsky has commenced the class action Mineff v. Egalet Corporation, et al. (Case No. 2:17-cv-00390-MMB) in the USDC for the Eastern District of Pennsylvania. Click here to view the complaint. To get more information go to: ...
EGLT SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Invest...
NEW YORK--(BUSINESS WIRE)-- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Eastern District of Pennsylvania on behalf of investors who purchased Egalet Corporation (NASDAQ:EGLT) securities between December 15, 2015 and January 9, 2017. Click here to learn about the case: http://www.wongesq.com/pslra/egalet-corporation. There is no cost or obligation to you. The complaint alleges that, among other allegations, throughout the Class Period, Egalet made materia...
DEADLINE ALERT: Brower Piven Alerts Shareholders Of Approaching Deadli...
STEVENSON, Md.--(BUSINESS WIRE)-- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Eastern District of Pennsylvania on behalf of purchasers of Egalet Corporation (Nasdaq: EGLT) (“Egalet” or the “Company”) securities during the period between December 15, 2015 and January 9, 2017, inclusive (the “Class Period”). Investors who wish to become proactively involved in the litigation have until March 28, 2017 t...
INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders It Has File...
NEW YORK--(BUSINESS WIRE)-- The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired shares of Egalet Corporation (“Egalet”) (NASDAQ: EGLT) between December 15, 2015 and January 9, 2017. You are hereby notified that Levi & Korsinsky has commenced the class action Mineff v. Egalet Corporation, et al. (Case No. 2:17-cv-00390-MMB) in the USDC for the Eastern District of Pennsylvania. Click here to view the complaint. To get more information go to: ...
EGLT SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Invest...
NEW YORK--(BUSINESS WIRE)-- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Eastern District of Pennsylvania on behalf of investors who purchased Egalet Corporation (NASDAQ:EGLT) securities between December 15, 2015 and January 9, 2017. Click here to learn about the case: http://www.wongesq.com/pslra/egalet-corporation. There is no cost or obligation to you. The complaint alleges that, among other allegations, throughout the Class Period, Egalet made materia...
EGLT LOSS NOTICE: Rosen Law Firm Reminds Egalet Corporation Investors ...
NEW YORK--(BUSINESS WIRE)-- Rosen Law Firm, a global investor rights law firm, reminds purchasers of Egalet Corporation securities (NASDAQ:EGLT) from December 15, 2015 through January 9, 2017, inclusive (the “Class Period”) of the important March 28, 2017 lead plaintiff deadline in the class action. The lawsuit seeks to recover damages for Egalet investors under the federal securities laws. To join the Egalet class action, go to http://rosenlegal.com/cases-1046.html or call Phillip Kim, Esq. or Kevin Chan, Esq. toll-free at 8...
INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses I...
STEVENSON, Md.--(BUSINESS WIRE)-- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Eastern District of Pennsylvania on behalf of purchasers of Egalet Corporation (Nasdaq: EGLT) (“Egalet” or the “Company”) securities during the period between December 15, 2015 and January 9, 2017, inclusive (the “Class Period”). Investors who wish to become proactively involved in the litigation have until March 28, 2017 t...
IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class...
IRVINE, Calif.--(BUSINESS WIRE)-- Khang & Khang LLP (the “Firm”) announces the filing of a class action lawsuit against Egalet Corporation (“Egalet” or the “Company”) (Nasdaq: EGLT). Investors who purchased or otherwise acquired Egalet shares between December 15, 2015, and January 9, 2017, inclusive (the “Class Period”), are encouraged to contact the firm in advance of the March 28, 2017 lead plaintiff deadline. If you purchased shares of Egalet during the Class Period, please contact Joon M. Khang, Esquire, of Khang & Khang,...
EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Acti...
NEW YORK--(BUSINESS WIRE)-- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Egalet Corporation securities (NASDAQ: EGLT) from December 15, 2015 through January 9, 2017, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Egalet investors under the federal securities laws. To join the Egalet class action, go to http://rosenlegal.com/cases-1046.html or call Phillip Kim, Esq. or Kevin Chan, Esq. toll-free at 866-767-3653 or email pk...
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Co...
NEW YORK--(BUSINESS WIRE)-- Levi & Korsinsky announces it has commenced an investigation of Egalet Corporation (NASDAQ:EGLT) (“Egalet”) concerning possible violations of federal securities laws by the Company and/or certain of its officers and directors. On January 9, 2017, Egalet issued a press release announcing the approval of its product Arymo ER. Later that day the U.S. Federal Drug Administration issued a statement announcing that another product called MorphaBond “has marketing exclusivity for labeling describing the ...
Insider sold after exercising options/sold: Two Directors sold after e...
Two Directors at Egalet Corp sold after exercising options/sold 34,236 shares at between 7.550USD and 7.690USD. The significance rating of the trade was 53/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the c...
QuickView: Innovating abuse deterrent drugs
In late December, Egalet submitted an NDA for its Arymo ER abuse-deterrent (AD) morphine tablet – a widely prescribed opiate with few AD competitors. Management expects to complete clinical trials in early 2017 to support a mid 2017 NDA filing for its AD oxycodone tablet. If approved, this will open Egalet to the $2.5bn market for oxycontin with a proprietary AD formulation.
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.